CN112142748A
|
|
Pyrazolone pyrimidine compound, preparation method and application thereof
|
CN112142747A
|
|
Pyrazolone pyrimidine compound, preparation method and application thereof
|
CN112142763A
|
|
Pyrazolone pyrimidine compound, preparation method and application thereof
|
WO2020200303A1
|
|
Immune cell containing tumor antigen recognition receptor and application thereof
|
WO2020108659A1
|
|
Nitrogen-containing heterocyclic compound and composition thereof, preparation method therefor, and application thereof
|
CN111202845A
|
|
Pharmaceutical formulations comprising anti-CD 20 antibodies, methods of making and uses thereof
|
CN111039941A
|
|
Nitrogen-containing heterocyclic compound, preparation method and application thereof
|
CN111978332A
|
|
Maytansine dechloride, midbody, preparation method and application thereof
|
CN111888351A
|
|
Application of marigold
|
CN111888346A
|
|
Application of aurantio-obtusin
|
CN111888373A
|
|
Application of cordycepin or pharmaceutically acceptable salt thereof
|
CN111763152A
|
|
Preparation method of acetamido substance
|
WO2019174631A1
|
|
Method for preparing norstat
|
CN109553679A
|
|
High-purity ulinastatin and preparation method thereof and pharmaceutical composition containing ulinastatin
|
AU2019218153A1
|
|
Therapeutic drug for neurodegenerative disease and application thereof
|
CN109507343A
|
|
UPLC method quickly measures west safflower active constituent content and identifies illegal dyeing
|
CN109619333A
|
|
A kind of ginseng safflower liquid beverage and preparation method thereof
|
CN111253369A
|
|
Benzene sulfonate, preparation method thereof and application of benzene sulfonate in preparation of dabigatran etexilate
|
WO2019096322A1
|
|
Pyrazolone-pyrimidine compound, preparation method therefor and application thereof
|
CN111170881A
|
|
Preparation method of brivaracetam intermediate
|